1. Home
  2. GNLX vs DHY Comparison

GNLX vs DHY Comparison

Compare GNLX & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • DHY
  • Stock Information
  • Founded
  • GNLX 2001
  • DHY 1998
  • Country
  • GNLX United States
  • DHY United States
  • Employees
  • GNLX N/A
  • DHY N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • DHY Finance/Investors Services
  • Sector
  • GNLX Health Care
  • DHY Finance
  • Exchange
  • GNLX Nasdaq
  • DHY Nasdaq
  • Market Cap
  • GNLX 184.4M
  • DHY 202.0M
  • IPO Year
  • GNLX 2023
  • DHY N/A
  • Fundamental
  • Price
  • GNLX $2.96
  • DHY $2.03
  • Analyst Decision
  • GNLX Strong Buy
  • DHY
  • Analyst Count
  • GNLX 4
  • DHY 0
  • Target Price
  • GNLX $17.75
  • DHY N/A
  • AVG Volume (30 Days)
  • GNLX 138.3K
  • DHY 569.1K
  • Earning Date
  • GNLX 05-06-2025
  • DHY 01-01-0001
  • Dividend Yield
  • GNLX N/A
  • DHY 9.10%
  • EPS Growth
  • GNLX N/A
  • DHY N/A
  • EPS
  • GNLX N/A
  • DHY N/A
  • Revenue
  • GNLX N/A
  • DHY N/A
  • Revenue This Year
  • GNLX N/A
  • DHY N/A
  • Revenue Next Year
  • GNLX N/A
  • DHY N/A
  • P/E Ratio
  • GNLX N/A
  • DHY N/A
  • Revenue Growth
  • GNLX N/A
  • DHY N/A
  • 52 Week Low
  • GNLX $1.60
  • DHY $1.77
  • 52 Week High
  • GNLX $5.89
  • DHY $2.08
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 54.28
  • DHY 48.82
  • Support Level
  • GNLX $2.26
  • DHY $1.92
  • Resistance Level
  • GNLX $3.06
  • DHY $2.00
  • Average True Range (ATR)
  • GNLX 0.31
  • DHY 0.03
  • MACD
  • GNLX 0.04
  • DHY 0.01
  • Stochastic Oscillator
  • GNLX 78.42
  • DHY 65.00

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.

Share on Social Networks: